Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.730
-0.030 (-1.70%)
At close: Mar 28, 2025, 4:00 PM
1.760
+0.030 (1.73%)
After-hours: Mar 28, 2025, 7:56 PM EDT

Inovio Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
65.8114.3146.3371.14250.73
Upgrade
Short-Term Investments
28.3130.98206.67330.17160.91
Upgrade
Cash & Short-Term Investments
94.11145.29253401.31411.64
Upgrade
Cash Growth
-35.23%-42.57%-36.96%-2.51%359.76%
Upgrade
Receivables
1.22.4111.748.0319.06
Upgrade
Prepaid Expenses
2.525.4120.5139.14.8
Upgrade
Other Current Assets
--30-35.66
Upgrade
Total Current Assets
97.83153.11315.24448.44471.17
Upgrade
Property, Plant & Equipment
11.7714.4517.9629.0224.09
Upgrade
Long-Term Investments
1.612.782.013.914.89
Upgrade
Goodwill
--10.5110.5110.51
Upgrade
Other Intangible Assets
--2.132.633.15
Upgrade
Other Long-Term Assets
1.980.610.681.4325.96
Upgrade
Total Assets
113.2170.95348.53495.94539.77
Upgrade
Accounts Payable
6.444.6521.0827.971.47
Upgrade
Accrued Expenses
13.1318.6426.4230.5530.08
Upgrade
Current Portion of Long-Term Debt
-16.77---
Upgrade
Current Portion of Leases
2.52.412.82.62.33
Upgrade
Current Unearned Revenue
-0.112.564.627.58
Upgrade
Other Current Liabilities
13.26-44-0.25
Upgrade
Total Current Liabilities
35.3342.5796.8765.7441.71
Upgrade
Long-Term Debt
--16.6114.9618.66
Upgrade
Long-Term Leases
9.3711.0312.6615.4618.06
Upgrade
Long-Term Unearned Revenue
---0.060.12
Upgrade
Long-Term Deferred Tax Liabilities
--0.030.030.03
Upgrade
Other Long-Term Liabilities
---0.010.06
Upgrade
Total Liabilities
44.6953.6126.1796.2778.63
Upgrade
Common Stock
0.040.020.020.220.19
Upgrade
Additional Paid-In Capital
1,7991,7411,7111,6101,367
Upgrade
Retained Earnings
-1,730-1,623-1,488-1,210-906.2
Upgrade
Comprehensive Income & Other
-0.68-0.66-0.7-0.28-0.26
Upgrade
Total Common Equity
68.5117.35222.36399.67461.14
Upgrade
Shareholders' Equity
68.5117.35222.36399.67461.14
Upgrade
Total Liabilities & Equity
113.2170.95348.53495.94539.77
Upgrade
Total Debt
11.8730.2132.0733.0239.05
Upgrade
Net Cash (Debt)
82.25115.08220.92368.29372.59
Upgrade
Net Cash Growth
-28.53%-47.91%-40.01%-1.16%-
Upgrade
Net Cash Per Share
3.035.1911.1121.1628.82
Upgrade
Filing Date Shares Outstanding
36.6723.3721.6818.1217.3
Upgrade
Total Common Shares Outstanding
36.122.7921.0918.1215.57
Upgrade
Working Capital
62.5110.54218.37382.7429.46
Upgrade
Book Value Per Share
1.905.1510.5422.0629.62
Upgrade
Tangible Book Value
68.5117.35209.72386.53447.48
Upgrade
Tangible Book Value Per Share
1.905.159.9421.3428.74
Upgrade
Machinery
8.369.913.4920.5912.16
Upgrade
Leasehold Improvements
11.7615.9215.815.815.18
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q